Summary:
mr strittmatter and his co-author christopher van dyck have already started a 'multi-site clinical trial ' to determine whether the drug can also benefit alzheimer 's patients .
as we learn more about the causes of dementia , there is hope that treatments we routinely use for other diseases may also work for people with dementia . '
